期刊文献+

肿瘤浸润相关性微小RNA在膀胱尿路上皮癌中表达的初步研究 被引量:5

The infiltration related miRNAs in bladder urothelial carcinoma
原文传递
导出
摘要 目的筛选及验证膀胱尿路上皮癌中肿瘤浸润相关性微小RNA(miRNA)的表达。方法2009年2月至2010年4月随机收集膀胱尿路上皮癌标本20例,肌层浸润组12例,非浸润组8例。采用miRNA芯片分析筛选出肿瘤浸润相关性miRNA。再随机收集膀胱尿路上皮癌标本22例,浸润组15例,非浸润组7例,购置膀胱尿路上皮癌细胞株EJ、5637、T24、BIU-87等4型,采用RT—PCR法验证miRNA基因芯片结果。结果浸润组与非浸润组有7个差异表达基因,hsa—miR-29c、hsa—miR-200a、hsa.miR.378、hsa,miR-429、hsa—miR-200c、hsa—miR-141等上调,hsa-miR-451下调。选取5个miRNAs的RT—PCR验证结果与基因芯片结果一致。膀胱尿路上皮癌T24细胞株5个miRNAs的验证结果与基因芯片结果一致。结论膀胱尿路上皮癌的浸润、进展与miRNA的差异表达密切相关。 Objective To figure out and verify infiltration related miRNAs in bladder urothelial carcinoma (BUC). Methods Fresh tissues (20 samples, 12 were infiltrative BUC samples, 8 were non-infiltrative BUC samples) were collected in liquid nitrogen. The total RNA was extracted by using Trizol reagents. RNA quality control; miRNA microarray hybridization; data analysis. Another 22 samples were collected in fresh (15 were infiltrative BUC samples, 7 were non-infiltrative BUC samples) for verifying purpose. 4 types of bladder cancer cell lines were used for the study. BUC cell strain ; total RNA was extracted by Trizol reagents; RNA quality control; RT-PCR and analysis of the data. Results ①In infiltrative BUC group, compared with non-infiltrative BUC group, there were 7 differentially expressed miRNAs: hsa-miR- 29e, hsa-miR-200a, hsa-miR-378, hsa-miR-429, hsa-miR-200e and hsa-miR-141 were up-regulated; hsamiR-451 was down-regulated.②In collected samples, the result of RT-PCR was consistent with miRNA array. ③In bladder cancer cell lines, only the results of T24 were consistent with miRNA array. Conclusion Infiltration of BUC might relate with different expression of miRNAs.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2012年第7期540-543,共4页 Chinese Journal of Urology
基金 国家自然科学基金(30772278)
关键词 微小RNA 膀胱尿路上皮癌 肿瘤浸润相关特异性miRNA 逆转录聚合酶链 反应 miRNA Bladder urotbelial carcinoma Infiltration related miRNA RT-PCR
  • 相关文献

参考文献17

  • 1Ying SY, Chang DC, Lin SL. The microRNA (miRNA) : Over- view of the RNA genes that modulate gene function. Mol Biotecb- nol, 2008, 38: 257-268.
  • 2Calin GA, Liu CG, Sevignani C, et al. MicroRNA profiling re- veals distinct signatures in B cell chronic lymphocytic leukemias. Proe Natl Acad Sci U S A, 2004, 101 : 11755-11760.
  • 3Gottardo F, Liu CG, Fcrraein M, et al. Miero-RNA profiling in kidney and bladder cancers. Urol Oncol, 2007, 25 : 387-392.
  • 4Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. CancerCell, 2006, 9: 189-198.
  • 5胡明,林天歆,黄健,董文,许可慰,潘秋辉.微小RNA let-7基因表达在膀胱癌生物学行为中的作用[J].中华泌尿外科杂志,2009,30(12):824-826. 被引量:8
  • 6Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature, 2005, 435: 834-838.
  • 7Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of microR- NAs in vivo with "antagomirs". Nature, 2005, 438: 685-689.
  • 8Fontana L, Fiori ME, Albini S, et al. Antagomir-17-5p abol_i- shes the growth of therapy-resistant ncuroblastoma through p21 and BIM. PLoS One, 2008, 3: e2236.
  • 9Gregory PA, Bracken CP, Bert AG, et al. MicroRNAs as regula- tors of epithelial-mesenchymal transition. Cell Cycle, 2008, 7 : 3112-3118.
  • 10Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to meseuchymal transition by tar- geting ZEB1 and SIP1. Nat Cell Biol, 2008, 10: 593-601.

二级参考文献12

  • 1吴登龙,张元芳,关明,刘薇薇,徐月敏,金三宝,金重睿,张炯,吕元.蛋白质芯片技术筛选膀胱癌尿液标记物的研究[J].中华泌尿外科杂志,2004,25(7):453-455. 被引量:16
  • 2骆明勇,田志刚,徐智,张亮,王应雄,程京.一种检测microRNA表达的微阵列芯片的研制及应用[J].生物化学与生物物理进展,2007,34(1):31-41. 被引量:14
  • 3Bartel DP. MicroRNAs: genomies, biogenesis, mechanism, and function. Cell, 2004, 116: 281-297.
  • 4He H, Jazdzewski K, Li W, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A, 2005, 102: 19075-19580.
  • 5Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature, 2005, 435: 834-838.
  • 6Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A, 2006, 103: 2257-2261.
  • 7Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let 7 microRNAs in human lung cancers in association with shortened postoperative survival Cancer Res, 2004, 64: 3753-3756.
  • 8Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A, 2004, 101: 2999-3004_.
  • 9孙颖浩,杨庆,王林辉,许传亮,应康,唐榕,李瑶,钱松溪.人膀胱癌基因表达变化的基因芯片研究[J].中华泌尿外科杂志,2001,22(6):325-328. 被引量:9
  • 10周利群,陈为民,那彦群,黄有媛,冯陶,郝金瑞,潘柏年,薛兆英,顾方六,郭应禄.良性前列腺增生与前列腺癌患者血清总PSA水平与游离PSA比值的比较[J].中华泌尿外科杂志,2002,23(6):354-357. 被引量:74

共引文献17

同被引文献69

  • 1Slaby O, Jancovicova J, Lakomy R, et al. Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for predic- tion of early metastasis after nephrectomy [J]. Journal of Experi- mental & Clinical Cancer Research: CR, 2010, 29: 90.
  • 2Croce CM. Causes and consequences of microRNA dysregulation in cancer [J]. Nature Reviews Genetics, 2009, 10(10): 704-714.
  • 3Zimmerman AL, Wu S. MicroRNAs, cancer and cancer stem cells [.I]. Cancer Letters, 2011, 300(1): 10-19.
  • 4Corcoran C, Friel AM, Duffy MJ, et al. Intracellular and extracellular microRNAs in breast cancer [J]. Clinical Chemistry, 2011, 57(1): 18-32.
  • 5Bartels CL, Tsongalis GJ. MicroRNAs: novel biomarkers for human cancer [J]. Clinical Chemistry, 2009, 55(4): 623-631.
  • 6Slaby O, Svoboda M, Michalek J, et al. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application [J]. Molecular cancer, 2009, 8: 102.
  • 7Redova M, Svoboda M, Slaby O. MicroRNAs and their target gene networks in renal cell carcinoma [J]. Biochemical and Biophysical Research Communications, 2011, 405(2): 153-156.
  • 8Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-de- rived exosomes as diagnostic biomarkers of ovarian cancer [J]. Gy- necologic Cncology, 2008, 110(I): 13-21.
  • 9Schmittgen TD, Livak KJ. Analyzing real-time PCR data by thecomparative C(T) method [J]. Nature protocols, 2008, 3(6): 1101-1108.
  • 10Yi Z, Fu Y, Zhao S, et al. Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues [J]. Journal of Can- cer Research and Clinical Oncology, 2010, 136(6): 855-862.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部